Glanbia PLC
ISEQ:GL9
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Bristol-Myers Squibb Co
NYSE:BMY
|
Pharmaceuticals
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Altria Group Inc
NYSE:MO
|
Tobacco
|
|
US |
LL Flooring Holdings Inc
NYSE:LL
|
Retail
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Cloudflare Inc
NYSE:NET
|
Technology
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
14.08
19.19
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Bristol-Myers Squibb Co
NYSE:BMY
|
US | |
Abbvie Inc
NYSE:ABBV
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Altria Group Inc
NYSE:MO
|
US | |
LL Flooring Holdings Inc
NYSE:LL
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Cloudflare Inc
NYSE:NET
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
Coca-Cola Co
NYSE:KO
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one GL9 stock under the Base Case scenario is 18.58 EUR. Compared to the current market price of 14.75 EUR, Glanbia PLC is Undervalued by 21%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Glanbia PLC
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for GL9 cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Glanbia PLC
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Glanbia PLC
Balance Sheet Decomposition
Glanbia PLC
Current Assets | 1.5B |
Cash & Short-Term Investments | 300.9m |
Receivables | 524.4m |
Other Current Assets | 647.4m |
Non-Current Assets | 2.6B |
Long-Term Investments | 167.5m |
PP&E | 611.1m |
Intangibles | 1.8B |
Other Non-Current Assets | 16.4m |
Current Liabilities | 905.4m |
Accounts Payable | 598m |
Short-Term Debt | 175.6m |
Other Current Liabilities | 131.8m |
Non-Current Liabilities | 989.1m |
Long-Term Debt | 856.6m |
Other Non-Current Liabilities | 132.5m |
Earnings Waterfall
Glanbia PLC
Revenue
|
4.5B
USD
|
Cost of Revenue
|
-3.3B
USD
|
Gross Profit
|
1.2B
USD
|
Operating Expenses
|
-831.8m
USD
|
Operating Income
|
372.1m
USD
|
Other Expenses
|
-78m
USD
|
Net Income
|
294.1m
USD
|
Free Cash Flow Analysis
Glanbia PLC
USD | |
Free Cash Flow | USD |
Glanbia has surpassed its expectations in the first half of 2023 with a 6.6% growth in constant currency, driving an upgrade in full-year adjusted earnings per share guidance from 7-11% to 12-15%, all in constant currency. This positive outcome also supports a 10% increase in the interim dividend. Specifically, the Global Performance Nutrition (GPN) delivered robust H1 results with branded like-for-like revenues up by 3.7%, and earnings climbing over 20% year-on-year. The main drivers were pricing, which grew by almost 11%, and the strong performance of Optimum Nutrition (ON), which saw a 16% growth. Despite a 7.2% decline in branded volume mainly due to SlimFast, the ON brand and international volume and pricing are doing well, setting up a positive future outlook. Furthermore, due to stronger than expected margin progression, GPN's full-year '23 margin guidance will be upgraded by an additional 100 basis points, from an initial range of 12.5%-13.5% to a new range of 13.5%-14.5%. The group's overall financial position remains robust, with a debt-to-EBITDA ratio under 1x, and investments continuing in key strategic areas like talent, marketing, and innovation. Revenue growth is anticipated to be at the lower end of the projected 5-7% range, primarily due to the weight management decline offsetting growth in other areas.
What is Earnings Call?
GL9 Profitability Score
Profitability Due Diligence
Glanbia PLC's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
Score
Glanbia PLC's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
GL9 Solvency Score
Solvency Due Diligence
Glanbia PLC's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Score
Glanbia PLC's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
GL9 Price Targets Summary
Glanbia PLC
According to Wall Street analysts, the average 1-year price target for GL9 is 21.15 EUR with a low forecast of 17.17 EUR and a high forecast of 27.3 EUR.
Dividends
Current shareholder yield for GL9 is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Glanbia Plc engages in the manufacture and distribution of dairy and nutritional ingredients. The company is headquartered in Kilkenny, Kilkenny and currently employs 8,071 full-time employees. The firm operates through two segments: Glanbia Performance Nutrition and Glanbia Nutritionals. The firm's Glanbia Performance Nutrition segment includes performance nutrition products. Its products are sold through a range of channels, including specialty retail, the Internet and gyms in a range of formats, including powders, bars and ready-to-drink beverages. The firm's Glanbia Nutritionals segment provides nutritional solutions. The company manufactures and sells cheese, dairy and non-dairy nutritional ingredients and vitamin and mineral premixes targeting the market focus on health and nutrition.
Contact
IPO
Employees
Officers
The intrinsic value of one GL9 stock under the Base Case scenario is 18.58 EUR.
Compared to the current market price of 14.75 EUR, Glanbia PLC is Undervalued by 21%.